|
Status |
Public on Jul 04, 2016 |
Title |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML |
Organisms |
Homo sapiens; Mus musculus |
Experiment type |
Expression profiling by array Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
May 11, 2016 |
Last update date |
May 15, 2019 |
Contact name |
Medhanie Assmelash Mulaw |
E-mail(s) |
medhanie.mulaw@uni-ulm.de
|
Organization name |
University of Ulm
|
Street address |
Albert-Einstein-Allee 11
|
City |
Ulm |
ZIP/Postal code |
89081 |
Country |
Germany |
|
|
Platforms (4)
|
GPL6246 |
[MoGene-1_0-st] Affymetrix Mouse Gene 1.0 ST Array [transcript (gene) version] |
GPL9052 |
Illumina Genome Analyzer (Homo sapiens) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
|
Samples (36)
|
|
This SuperSeries is composed of the following SubSeries:
|
GSE81174 |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [Affymetrix] |
GSE81321 |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [ChIP-Seq] |
GSE81328 |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] |
GSE81329 |
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq mouse] |
|
Relations |
BioProject |
PRJNA321303 |